{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:14:06Z","timestamp":1793459646886,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jiac.2025.102726","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T18:28:52Z","timestamp":1746728932000},"page":"102726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of initial combination therapy with anti-SARS-CoV-2 antivirals targeting viral clearance in COVID-19 patients with B-cell lymphoma treated with anti-CD20 antibodies: A retrospective single-centre study in Japan"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9836-2870","authenticated-orcid":false,"given":"Shuhei","family":"Maruyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Kashihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Shimazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukuki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Nakamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Kuwagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jiac.2025.102726_bib1","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/ajh.26209","article-title":"Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy","volume":"96","author":"Dul\u00e9ry","year":"2021","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.jiac.2025.102726_bib2","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1016\/S2665-9913(21)00059-X","article-title":"COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study","volume":"3","author":"Avouac","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"5","key":"10.1016\/j.jiac.2025.102726_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/ejh.13926","article-title":"Global reported impacts of COVID-19 on lymphoma patients and the emerging clinical management approaches in response to the ongoing pandemic","volume":"110","author":"Elliott","year":"2023","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.jiac.2025.102726_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/2159-8290.CD-21-1033","article-title":"Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies","volume":"12","author":"Lee","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jiac.2025.102726_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40164-022-00307-9","article-title":"Novel treatment combining antiviral and neutralizing antibody-based therapies with monitoring of spike-specific antibody and viral load for immunocompromised patients with persistent COVID-19 infection","volume":"11","author":"Wada","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.jiac.2025.102726_bib6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1186\/s12879-023-08797-6","article-title":"Clinical experience of treatment of immunocompromised individuals with persistent SARS-CoV-2 infection based on drug resistance mutations determined by genomic analysis: a descriptive study","volume":"23","author":"Shimazu","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jiac.2025.102726_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1186\/s12879-024-09631-3","article-title":"The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody","volume":"24","author":"Maruyama","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.jiac.2025.102726_bib8","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hon.3206","article-title":"Dual combined antiviral treatment with remdesivir and nirmatrelvir\/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection","volume":"41","author":"Pasquini","year":"2023","journal-title":"Hematol Oncol"},{"issue":"2","key":"10.1016\/j.jiac.2025.102726_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/cid\/ciad181","article-title":"Triple combination therapy with 2 antivirals and monoclonal antibodies for persistent or relapsed severe acute respiratory syndrome coronavirus 2 infection in immunocompromised patients","volume":"77","author":"Mikulska","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jiac.2025.102726_bib10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/cid\/ciac847","article-title":"Dual antiviral therapy for persistent coronavirus disease 2019 and associated organizing pneumonia in an immunocompromised host","volume":"76","author":"Trottier","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jiac.2025.102726_bib11","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/cid\/ciad085","article-title":"Successful combination treatment for persistent severe acute respiratory syndrome coronavirus 2 infection","volume":"76","author":"Blennow","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jiac.2025.102726_bib12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/cid\/ciac868","article-title":"Successful treatment of prolonged, severe coronavirus disease 2019 lower respiratory tract disease in a B cell acute lymphoblastic leukemia patient with an extended course of remdesivir and nirmatrelvir\/ritonavir","volume":"76","author":"Ford","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102726_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijid.2023.04.412","article-title":"Combination regimen of nirmatrelvir\/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: a case report and a scoping review of the literature","volume":"133","author":"Marangoni","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2025.102726_bib14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMc2119407","article-title":"Efficacy of antibodies and antiviral drugs against Covid-19 omicron variant","volume":"386","author":"Takashita","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102726_bib15","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMc2201933","article-title":"Efficacy of antiviral agents against the SARS-CoV-2 omicron subvariant BA.2","volume":"386","author":"Takashita","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102726_bib16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMc2207519","article-title":"Efficacy of antibodies and antiviral drugs against Omicron BA.2.12.1, BA.4, and BA.5 subvariants","volume":"387","author":"Takashita","year":"2022","journal-title":"N Engl J Med"},{"issue":"7979","key":"10.1016\/j.jiac.2025.102726_bib17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41586-023-06487-6","article-title":"Neutralization, effector function and immune imprinting of Omicron variants","volume":"621","author":"Addetia","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jiac.2025.102726_bib19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/bjh.19143","article-title":"Prolonged shedding of viable SARS- CoV-2 in immunocompromised patients with haematological malignancies: a prospective study","volume":"204","author":"Ichikawa","year":"2024","journal-title":"Br J Haematol"},{"issue":"656","key":"10.1016\/j.jiac.2025.102726_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo0718","article-title":"Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms","volume":"14","author":"Stevens","year":"2022","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.jiac.2025.102726_bib21","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1038\/s41467-023-40018-1","article-title":"In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir","volume":"14","author":"Kiso","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiac.2025.102726_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105814","article-title":"Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains","volume":"222","author":"Bouzidi","year":"2024","journal-title":"Antivir Res"},{"issue":"13","key":"10.1016\/j.jiac.2025.102726_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade8778","article-title":"Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors","volume":"9","author":"Moghadasi","year":"2023","journal-title":"Sci Adv"},{"issue":"3","key":"10.1016\/j.jiac.2025.102726_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.103004","article-title":"Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease","volume":"299","author":"Noske","year":"2023","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jiac.2025.102726_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105969","article-title":"Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system","volume":"231","author":"Rauch","year":"2024","journal-title":"Antivir Res"},{"issue":"3","key":"10.1016\/j.jiac.2025.102726_bib26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41422-022-00618-w","article-title":"SARS\u2010CoV\u20102 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination","volume":"32","author":"Li","year":"2022","journal-title":"Cell Res"},{"issue":"11","key":"10.1016\/j.jiac.2025.102726_bib27","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.3390\/v14112429","article-title":"An optimized bioassay for screening combined anticoronaviral compounds for efficacy against feline infectious peritonitis virus with pharmacokinetic analyses of GS\u2010441524, remdesivir, and molnupiravir in cats","volume":"14","author":"Cook","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.jiac.2025.102726_bib28","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41467-022-29104-y","article-title":"De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS\u2010CoV\u20102 infection in an immunocompromised patient: a case report","volume":"13","author":"Gandhi","year":"2022","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.jiac.2025.102726_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009929","article-title":"In vitro selection of remdesivir resistance suggests evolutionary predictability of SARS-CoV-2","volume":"17","author":"Szemiel","year":"2021","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.jiac.2025.102726_bib30","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1038\/s41467-024-47941-x","article-title":"Dynamic diversity of SARS-CoV-2 genetic mutations in a lung transplantation patient with persistent COVID-19","volume":"15","author":"Igari","year":"2024","journal-title":"Nat Commun"},{"issue":"7944","key":"10.1016\/j.jiac.2025.102726_bib31","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-022-05514-2","article-title":"Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir","volume":"613","author":"Iketani","year":"2023","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jiac.2025.102726_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00697-22","article-title":"A randomized phase 2\/3 study of ensitrelvir, a novel oral SARS-CoV-2 3C-like protease inhibitor, in Japanese patients with mild-to-moderate COVID-19 or asymptomatic SARS-CoV-2 infection: results of the phase 2a part","volume":"66","author":"Mukae","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102726_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106118","article-title":"M49L and other drug resistance mutations emerging in individuals after administration of ensitrelvir in Japanese clinical settings","volume":"236","author":"Inoue","year":"2025","journal-title":"Antivir Res"},{"issue":"11","key":"10.1016\/j.jiac.2025.102726_bib34","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S1473-3099(24)00353-0","article-title":"Comparative effectiveness of combination therapy with nirmatrelvir\u2013ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir\u2013ritonavir in patients hospitalised with COVID-19: a target trial emulation study","volume":"24","author":"Ming","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2025.102726_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1322594","article-title":"Bendamustine impairs humoral but not cellular immunity to SARS-CoV-2 vaccination in rituximab-treated B-cell lymphoma\u2013affected patients","volume":"14","author":"Vanni","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiac.2025.102726_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/jiaa666","article-title":"Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient","volume":"223","author":"Baang","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiac.2025.102726_bib37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jiac.2020.12.001","article-title":"Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient","volume":"27","author":"Nakajima","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2025.102726_bib38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13756-022-01067-1","article-title":"Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values","volume":"11","author":"Thornton","year":"2022","journal-title":"Antimicrob Resist Infect Control"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T07:03:07Z","timestamp":1749711787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25001230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1341321X25001230"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102726","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of initial combination therapy with anti-SARS-CoV-2 antivirals targeting viral clearance in COVID-19 patients with B-cell lymphoma treated with anti-CD20 antibodies: A retrospective single-centre study in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102726","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102726"}}